Pictet Asset Management
JAZZ icon

Pictet Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Pictet Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.1M Sell
147,599
-25,651
-15% -$5.62M 0.03% 402
2026
Q1 		$31.8M Sell
173,250
-11,446
-6% -$2M 0.03% 395
2025
Q4 		$31.5M Sell
184,696
-33,547
-15% -$5.14M 0.03% 414
2025
Q3 		$28.2M Sell
218,243
-8,592
-4% -$1.03M 0.03% 447
2025
Q2 		$24.2M Buy
226,835
+19,195
+9% +$2.09M 0.02% 463
2025
Q1 		$25.5M Sell
207,640
-4,080
-2% -$532K 0.03% 434
2024
Q4 		$26.1M Sell
211,720
-13,495
-6% -$1.59M 0.03% 429
2024
Q3 		$25M Sell
225,215
-13,706
-6% -$1.5M 0.03% 429
2024
Q2 		$25.5M Sell
238,921
-308,834
-56% -$34M 0.03% 405
2024
Q1 		$66M Sell
547,755
-30,442
-5% -$3.73M 0.07% 263
2023
Q4 		$71.1M Buy
578,197
+102,129
+21% +$12.7M 0.08% 250
2023
Q3 		$61.6M Buy
+476,068
New +$63.4M 0.08% 259

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Pictet Asset Management's JAZZ Position: Q2 2026 in Review

Pictet Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 15% in Q2 2026, selling an estimated $5.62M and leaving 147,599 shares worth $35.1M. The position accounts for 0.03% of the portfolio, ranked #402.

Pictet Asset Management first reported a position in JAZZ in Q3 2023 and has held it in 12 quarters since. The position peaked at $71.1M in Q4 2023. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Pictet Asset Management held 147,599 shares of Jazz Pharmaceuticals worth $35.1M as of Q2 2026.
  • Pictet Asset Management sold 25,651 Jazz Pharmaceuticals shares in Q2 2026, an estimated $5.62M.
  • Jazz Pharmaceuticals made up 0.03% of Pictet Asset Management's portfolio in Q2 2026, its #402 holding.
  • Pictet Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Jazz Pharmaceuticals position peaked at $71.1M in Q4 2023.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.